Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
1.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
01:20COPD: Pathogenesis and Clinical Features
642
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
642
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.2K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
High diagnostic yield of ultrasound-guided core needle biopsy of lymphadenopathy performed in an internal medicine department.
Revista clinica espanola·2025
Same author
Beyond acute SARS-CoV-2 infection: A new challenge for Internal Medicine.
Revista clinica espanola·2022
Same author
[Beyond acute SARS-CoV-2 infection: A new challenge for Internal Medicine].
Revista clinica espanola·2021
Same author
Adequacy and prognostic impact of treatment for severe exacerbation of chronic obstructive pulmonary disease.
Revista clinica espanola·2019
Same author
Renal function at admission as a prognostic marker for patients hospitalised for a first episode of heart failure. Results of the PREDICE study.
Revista clinica espanola·2019
Same author
Delphi-RAND consensus of the Spanish Society of Internal Medicine on the controversies in anticoagulant therapy and prophylaxis in medical diseases. INTROMBIN Project (Uncertainty in thromboprophylaxis in internal medicine).
Revista clinica espanola·2018
Same journal
Vaccination status of patients undergoing HIV treatment in a hospital in Madrid.
Revista clinica espanola·2026
Same journal
Sulfonylureas and fracture risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Revista clinica espanola·2026
Same journal
Risk factors for the development of in-hospital complications in pluripathological patients.
Revista clinica espanola·2026
Same journal
Features, treatment and 1-year prognosis of patients with heart failure and chronic kidney disease stages 4 or 5.
Revista clinica espanola·2026
Same journal
Notification of suspected adverse drug reactions by nurses to a hospital pharmacovigilance program. Retrospective descriptive study.
Revista clinica espanola·2026
Related Experiment Video
Updated: Sep 26, 2025
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
921
COPD: A preventable epidemic?
J M Varela-Aguilar1, F J Medrano-Ortega2
1Servicio de Medicina Interna, Hospital Universitario Virgen del Rocío, Sevilla, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain; Instituto de Biomedicina de Sevilla, Sevilla, Spain; Grupo de Trabajo de EPOC de la Sociedad Española de Medicina Interna, Spain.
Revista Clinica Espanola
|April 16, 2022
Summary
No abstract available in PubMed .
